Fusobacterium nucleatum Secretes Outer Membrane Vesicles and Promotes Intestinal Inflammation.
Melinda A. Engevik,Melinda A. Engevik,Heather A. Danhof,Wenly Ruan,Amy C. Engevik,Alexandra Chang-Graham,Kristen A. Engevik,Zhongcheng Shi,Zhongcheng Shi,Yanling Zhao,Colleen K. Brand,Evan S. Krystofiak,Susan Venable,Susan Venable,Xinli Liu,Kendal D. Hirschi,Joseph M. Hyser,Jennifer K. Spinler,Jennifer K. Spinler,Robert A. Britton,James Versalovic,James Versalovic +21 more
TLDR
Using mice harboring a human microbiome, it is demonstrated that F. nucleatum can promote inflammation, an effect which required antibiotic-mediated alterations in the gut microbiome, suggesting that an intact microbiome is protective against F.ucleatum-mediated immune responses.Abstract:
Multiple studies have implicated microbes in the development of inflammation, but the mechanisms remain unknown. Bacteria in the genus Fusobacterium have been identified in the intestinal mucosa of patients with digestive diseases; thus, we hypothesized that Fusobacterium nucleatum promotes intestinal inflammation. The addition of >50 kDa F. nucleatum conditioned media, which contain outer membrane vesicles (OMVs), to colonic epithelial cells stimulated secretion of the proinflammatory cytokines interleukin-8 (IL-8) and tumor necrosis factor (TNF). In addition, purified F. nucleatum OMVs, but not compounds 50-kDa compounds also stimulated TNF secretion, p-ERK, p-CREB, and NF-κB activation in human colonoid monolayers. In mice harboring a human microbiota, pretreatment with antibiotics and a single oral gavage of F. nucleatum resulted in inflammation. Compared to mice receiving vehicle control, mice treated with F. nucleatum showed disruption of the colonic architecture, with increased immune cell infiltration and depleted mucus layers. Analysis of mucosal gene expression revealed increased levels of proinflammatory cytokines (KC, TNF, IL-6, IFN-γ, and MCP-1) at day 3 and day 5 in F. nucleatum-treated mice compared to controls. These proinflammatory effects were absent in mice who received F. nucleatum without pretreatment with antibiotics, suggesting that an intact microbiome is protective against F. nucleatum-mediated immune responses. These data provide evidence that F. nucleatum promotes proinflammatory signaling cascades in the context of a depleted intestinal microbiome.IMPORTANCE Several studies have identified an increased abundance of Fusobacterium in the intestinal tracts of patients with colon cancer, liver cirrhosis, primary sclerosing cholangitis, gastroesophageal reflux disease, HIV infection, and alcoholism. However, the direct mechanism(s) of action of Fusobacterium on pathophysiological within the gastrointestinal tract is unclear. These studies have identified that F. nucleatum subsp. polymorphum releases outer membrane vesicles which activate TLR4 and NF-κB to stimulate proinflammatory signals in vitro Using mice harboring a human microbiome, we demonstrate that F. nucleatum can promote inflammation, an effect which required antibiotic-mediated alterations in the gut microbiome. Collectively, these results suggest a mechanism by which F. nucleatum may contribute to intestinal inflammation.read more
Citations
More filters
Journal ArticleDOI
Microbiome and cancer
Nyssa Cullin,Camila Azevedo Antunes,Ravid Straussman,Christoph K. Stein-Thoeringer,Eran Elinav,Eran Elinav +5 more
TL;DR: The human microbiome constitutes a complex multikingdom community that symbiotically interacts with the host across multiple body sites and has been suggested to influence the development, progression, metastasis formation, and treatment response of multiple cancer types as mentioned in this paper.
Journal ArticleDOI
Oral microbiota in human systematic diseases
TL;DR: In this article , the authors discussed emerging and exciting evidence of complex and important connections between the oral microbes and multiple human systemic diseases, and the possible contribution of the oral microorganisms to systemic diseases.
Journal ArticleDOI
Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality.
TL;DR: In this paper, the authors summarized the biological characteristics of Fusobacterium nucleatum and the epidemiological associations between F. nucleatum, and highlighted the mechanisms by which F.ucleatum participates in CRC progression, metastasis, and chemoresistance by affecting cancer cells or regulating the tumor microenvironment.
Journal ArticleDOI
How Microbes Affect Depression: Underlying Mechanisms via the Gut–Brain Axis and the Modulating Role of Probiotics
Kazunori Suda,Kazunori Matsuda +1 more
TL;DR: This review summarizes the current understanding of the molecular mechanisms involved in MDD onset, and discusses the therapeutic potential of probiotics, including butyrate-producing bacteria, which can mediate the microbiota–gut–brain axis.
Journal ArticleDOI
The role of mucins in gastrointestinal barrier function during health and disease.
Tom Breugelmans,Baptiste Oosterlinck,W. Arras,Hannah Ceuleers,Joris G. De Man,Georgina L. Hold,Benedicte Y. De Winter,Anne Marie G. A. de Smet +7 more
TL;DR: In this paper , the authors discuss the interactions between mucins and the gastrointestinal barrier function during health and disease and highlight the potential use of mucins in diagnosis, follow-up, and treatment of gastrointestinal diseases, such as chronic inflammatory diseases and cancer.
References
More filters
Journal ArticleDOI
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
TL;DR: This assay is very reproducible and rapid with the dye binding process virtually complete in approximately 2 min with good color stability for 1 hr with little or no interference from cations such as sodium or potassium nor from carbohydrates such as sucrose.
Journal ArticleDOI
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
Daniel N. Frank,Allison L. St. Amand,Robert A. Feldman,Edgar C. Boedeker,Noam Harpaz,Norman R. Pace +5 more
TL;DR: Patient stratification by GI microbiota provides further evidence that CD represents a spectrum of disease states and suggests that treatment of some forms of IBD may be facilitated by redress of the detected microbiological imbalances.
Journal ArticleDOI
Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium.
Toshiro Sato,Daniel E. Stange,Marc Ferrante,Marc Ferrante,Robert G.J. Vries,Johan H. van Es,Stieneke van den Brink,Winan J. van Houdt,Apollo Pronk,Joost van Gorp,Peter D. Siersema,Hans Clevers +11 more
TL;DR: A technology that can be used to study infected, inflammatory, or neoplastic tissues from the human gastrointestinal tract is developed that might have applications in regenerative biology through ex vivo expansion of the intestinal epithelia.
Journal ArticleDOI
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Dirk Gevers,Subra Kugathasan,Lee A. Denson,Yoshiki Vázquez-Baeza,Will Van Treuren,Boyu Ren,Emma Schwager,Dan Knights,Se Jin Song,Moran Yassour,Xochitl C. Morgan,Aleksandar Kostic,Chengwei Luo,Antonio Gonzalez,Daniel McDonald,Yael Haberman,Thomas D. Walters,Susan S. Baker,Joel R. Rosh,Michael C. Stephens,Melvin B. Heyman,James Markowitz,Robert N. Baldassano,Anne M. Griffiths,Francisco A. Sylvester,David R. Mack,Sandra C. Kim,Wallace Crandall,Jeffrey S. Hyams,Curtis Huttenhower,Curtis Huttenhower,Rob Knight,Rob Knight,Ramnik J. Xavier,Ramnik J. Xavier +34 more
TL;DR: Comparing the microbial signatures between the ileum, the rectum, and fecal samples indicates that at this early stage of disease, assessing the rectal mucosal-associated microbiome offers unique potential for convenient and early diagnosis of CD.
Journal ArticleDOI
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar Kostic,Aleksandar Kostic,Eunyoung Chun,Lauren Robertson,Jonathan N. Glickman,Carey Ann Gallini,Monia Michaud,Thomas E. Clancy,Thomas E. Clancy,Daniel C. Chung,Paul Lochhead,Georgina L. Hold,Emad M. El-Omar,Dean E. Brenner,Charles S. Fuchs,Matthew Meyerson,Matthew Meyerson,Wendy S. Garrett +17 more
TL;DR: Data suggest that, through recruitment of tumor-infiltrating immune cells, fusobacteria generate a proinflammatory microenvironment that is conducive for colorectal neoplasia progression, and this work finds that F.nucleatum does not exacerbate colitis, enteritis, or inflammation-associated intestinal carcinogenesis.
Related Papers (5)
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
Aleksandar Kostic,Aleksandar Kostic,Eunyoung Chun,Lauren Robertson,Jonathan N. Glickman,Carey Ann Gallini,Monia Michaud,Thomas E. Clancy,Thomas E. Clancy,Daniel C. Chung,Paul Lochhead,Georgina L. Hold,Emad M. El-Omar,Dean E. Brenner,Charles S. Fuchs,Matthew Meyerson,Matthew Meyerson,Wendy S. Garrett +17 more
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.
Chamutal Gur,Yara Ibrahim,Batya Isaacson,Rachel Yamin,Jawad Abed,Moriya Gamliel,Jonatan Enk,Yotam Bar-On,Noah Stanietsky-Kaynan,Shunit Coppenhagen-Glazer,Noam Shussman,Gideon Almogy,Angelica Cuapio,Erhard Hofer,Dror Mevorach,Adi Tabib,Rona Ortenberg,Gal Markel,Karmela Miklić,Stipan Jonjić,Caitlin A. Brennan,Wendy S. Garrett,Gilad Bachrach,Ofer Mandelboim +23 more